6P9B
HIV-1 Protease multiple drug resistant mutant PRS5B with Amprenavir
Summary for 6P9B
Entry DOI | 10.2210/pdb6p9b/pdb |
Related | 3NU3 |
Descriptor | HIV-1 protease, {3-[(4-AMINO-BENZENESULFONYL)-ISOBUTYL-AMINO]-1-BENZYL-2-HYDROXY-PROPYL}-CARBAMIC ACID TETRAHYDRO-FURAN-3-YL ESTER, PHOSPHATE ION, ... (4 entities in total) |
Functional Keywords | protease, inhibitor, multiple mutant, hydrolase-hydrolase inhibitor, viral protein complex, hydrolase/hydrolase inhibitor, viral protein |
Biological source | Human immunodeficiency virus type 1 group M subtype B (isolate BRU/LAI) (HIV-1) |
Total number of polymer chains | 2 |
Total formula weight | 22326.62 |
Authors | Kneller, D.W.,Agniswamy, J.,Weber, I.T. (deposition date: 2019-06-10, release date: 2020-04-15, Last modification date: 2023-10-11) |
Primary citation | Kneller, D.W.,Agniswamy, J.,Harrison, R.W.,Weber, I.T. Highly drug-resistant HIV-1 protease reveals decreased intra-subunit interactions due to clusters of mutations. Febs J., 287:3235-3254, 2020 Cited by PubMed: 31920003DOI: 10.1111/febs.15207 PDB entries with the same primary citation |
Experimental method | X-RAY DIFFRACTION (1.75 Å) |
Structure validation
Download full validation report